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Abstract
We herein describe the case of a 29-year-old woman with type 1 diabetes from 10 years of age who developed adult
cyclic vomiting syndrome. Beginning at 25 years of age, she was frequently hospitalized for stress-induced vomiting.
Her vomiting episodes developed acutely and remitted after severe vomiting of more than 30 times a day for a few
days. The vomiting periods were accompanied by leukocytosis with a predominance of neutrophils, high blood
pressure and fever. In addition, it was noted that her levels of both adrenocorticotropic hormone and antidiuretic
hormone during the vomiting attacks increased and subsequently dramatically decreased immediately after symptom
improvement; therefore, she was diagnosed with adult-type cyclic vomiting syndrome in accordance with the
diagnostic criteria of Rome III, a system developed to classify functional gastrointestinal disorders. Though glycemic
control had improved with continuous subcutaneous insulin infusion therapy, the vomiting frequency increased due to
the failure of drug treatments and general psychotherapy to terminate the vomiting attacks, making discharge difficult
and greatly interfering with everyday life. Eventually, hypnotherapy and miniature garden therapy were prescribed,
which significantly reduced the vomiting frequency, making it possible to discharge her from inpatient medical care.
In the treatment of this patient with type 1 diabetes and adult-type cyclic vomiting syndrome, continuous subcutaneous
insulin infusion therapy and comprehensive psychotherapy were effective.
Keywords: Type 1 diabetes mellitus, Cyclic vomiting syndrome (CVS), Continuous subcutaneous insulin infusion therapy
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Background
In type 1 diabetes mellitus, it has been shown that the
frequency of complications is reduced by the mainten-
ance of good glycemic control [1]. In addition, it has
been reported that patients with type 1 diabetes have
more frequent complications with feeding behavior
abnormalities and eating disorders [2, 3], as well as a
significantly faster progression of complications [4]. It
has especially been noted that complications of anorexia
nervosa significantly increase mortality [5].
The periodic vomiting of psychogenic vomiting disease
(cyclic vomiting syndrome or CVS) was reported in
1882 by Gee et al. [6], and is characterized by the
periodicity of severe vomiting episodes, followed by re-
mission, seen originally in 4-to 8-year-old children. Since
the report of CVS in adults by Abell et al. for the first
time in 1988 [7], the reported number of cases in adults
has also gradually increased, and the concept of adult
CVS (ACVS) has been established. In Japan, however,
ACVS is not common at present, and is not often recog-
nized. Currently, ACVS is defined as one of the func-
tional gastrointestinal disorders by the Rome III criteria.
Symptoms must persist for more than 6 months and
must meet all of the following 3 criteria: (1) there is an
episode of typical vomiting that remits in less than a
week after acute onset, (2) there are more than 3 epi-
sodes of intermittent vomiting in 1 year and (3) there is
an observed remission period between nausea or vomit-
ing episodes during the last three months. In addition,
as an auxiliary criterion, a personal or family history of
migraine has been raised [8]. The origin of ACVS is
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thought to be a result of overreaction of the hypothalamic-
pituitary-adrenal (HPA) axis at the time of psychological
stress or infection. In particular, corticotropin releasing
factor (CRF), which is secreted by the hypothalamus, is
believed to be an important trigger as the vomiting phase
begins. CRF, through stimulation of the hypersecretion of
adrenocorticotropic hormone (ACTH) and cortisol, con-
tributes to vomiting and promotes the synthesis of ketone
bodies due to an increase in plasma fatty acids and the in-
hibition of glycolysis. Moreover, CRF also inhibits gastro-
intestinal motility via regulation of the autonomic nervous
system (activation of the sympathetic nerve and suppres-
sion of the vagus nerve), and is thus believed to decrease
mechanisms that inhibit vomiting [9–11]. In addition, it
was revealed by Sato et al. in 1982 that ACTH, cortisol,
catecholamines, antidiuretic hormone (ADH) and prosta-
glandin E2 (PGE2) in the peripheral bloodstream were in-
creased by an excessive reaction of the HPA axis in one
group of children. This is referred to as the Sato variant.
That study particularly focused on patients with an in-
crease in ACTH and ADH during the vomiting period,
characterized by improvement and prompt remission, also
known as ACTH-ADH hypersecretory syndrome [12–14].
Others [15] have reported that a family history of migraine
is commonly recognized in patients with CVS. Another
pathophysiologic possibility is mitochondrial dysfunction
caused by mutations in mitochondrial DNA in which en-
ergy deficiency might trigger the onset of vomiting during
increased energy demand at the time of infection or stress,
as has been reported in pediatric patients [15–17]. Further-
more, because it has been reported that the reaction of re-
gions of the brain associated with anxiety such as the
cingulate cortex has changed [18], the response to stress in
our patient might have been excessive. In addition to these
factors, both the increased tendency toward synthesis of
ketone bodies in type 1 diabetes with poor glycemic con-
trol and decreased gastrointestinal motility with autonomic
neuropathy were also assumed to contribute to the vomit-
ing attacks (Fig. 1).
Continuous subcutaneous insulin infusion therapy
(CSII), since being used in many cases registered in the
Diabetes Control and Complication Trial (DCCT) [1],
Fig. 1 Pathologic hypothesis of disease. The secretion of ACTH and cortisol is increased by the oversecretion of CRF due to stress, while an
increase in catecholamines, PGE2, and ADH is seen. Vomiting episodes are induced by promoting ketone body synthesis due to an increase in
cortisol. The suppression of gastrointestinal motility by CRF is considered to be associated with vomiting. Increase in catecholamines and PGE2
may be related to hypertension and fever, respectively. If the family history of migraine is related to a fatty acid oxidation disorder caused by
mitochondrial DNA polymorphism, it may promote the ketone body synthesis. Furthermore, it is considered that autonomic dysfunction and lack
of insulin action associated with type 1 diabetes mellitus may facilitate vomiting attacks by the reduction of gastrointestinal motility and promotion of
ketone body synthesis. In addition, menstruation and increased reactivity of the cingulate cortex to stress stimuli may be associated with
excess secretion of CRF. The underlined text represents the findings observed in our case. PET, positron emission tomography; fMRI, functional
MRI; HPA, hypothalamic-pituitary-adrenal axis; CRF, corticotropin releasing factor; ACTH, adrenocorticotropic hormone; PGE2, prostaglandin E2;
ADH, antidiuretic hormone; CRP, C-reactive protein; T1DM, Type 1 diabetes mellitus
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has come to be widely recognized worldwide. CSII was
demonstrated to have stronger hypoglycemic action in
type 1 diabetes than multiple daily insulin injections
(MDI). The insulin requirement was also decreased and
was revealed to have a stabilizing effect on blood glucose
levels [19]. The improvement with CSII was reported to
be especially effective in patients with a hemoglobinA1c
(HbA1c) value of more than 8 % [20]. However, in ado-
lescent cases of type 1 diabetes, disease management
with CSII is not as effective because glycemic control
has also been shown to be unstable due to many other
factors [20]. On the other hand, it has been demon-
strated through meta-analysis that psychological inter-
ventions are associated with improvement in glycemic
control [21]. In recent years, approaches that focus on
psychological health have been important. Psychother-
apies such as hypnotherapy and play therapy were
included during traditional medical care. Hypnotherapy
was developed based on the research of Erickson, a well-
known psychiatrist and psychotherapist in the United
States and has also been reported as being efficacious for
Parkinson’s disease [22], migraine [23], anxiety and de-
pression [24]. Sandplay therapy was developed by Swiss
Jungian psychologist D.M. Kalff and has been defined as
a psychotherapeutic method that enables patients to
arrange miniature figures in a sandtray to create a “sand-
world” corresponding to various dimensions of their
social reality [25].
Here, we discuss a patient with type 1 diabetes compli-
cated by ACVS who had repeated vomiting attacks that
were especially difficult to control. We report that both
CSII and comprehensive psychotherapy, including hypno-
therapy and sandplay therapy, were effective.
Case presentation
The patient was a 29-year-old woman who had been in
good health until 1995, at which time she was diagnosed
at 10 years of age with type 1 diabetes with a positive
glutamate decarboxylase (GAD) antibody, and insulin
treatment was started. Although her mother had a his-
tory of migraines, no history of diabetes in her family
was observed.
Because she was bullied in elementary school due to
diabetes, she developed overeating behaviors and her
blood glucose levels became unstable; frequent hospitali-
zations were required and became pivotal to her daily
life. Unfortunately, the patient continued to experience
bullying even in junior high school, and her mother was
often absent from home due to work; so the patient
began overeating due to loneliness and anxiety. She was
then allowed admission to a pediatric long-term care fa-
cility where she was also bullied by other patients. In
addition, she was repeatedly hospitalized due to high
plasma glucose levels. Ultimately, she entered a nursing-
high school at the local hospital and graduated from jun-
ior high school. Following admission to the high school,
to perform education through distance learning, she
graduated at 20 years of age. During this period, she was
hospitalized for a psychosomatic illness when she was 17
years old. She was transferred from the local hospital to
another hospital’s pediatric unit. Furthermore, she began
to display signs of retinopathy and overt proteinuria.
In September 2007, at 23 years old, the patient first
visited our hospital through referral from the pediatrician
at the previous hospital as she had become an adult and
glycemic control was becoming increasingly difficult.
In December 2007, the patient, due to vomiting in
response to stressful events, was first admitted to our
hospital. On physical examination, her height was 158
cm, weight was 56.9 kg, BMI was 22.8 kg/m2, body
temperature was 38.4 °C, blood pressure was 146/91
mmHg, and pulse was 117 bpm and regular. Her cardio-
pulmonary examination was normal. She had no abnor-
mal abdominal findings. Her bilateral Achilles tendon
reflexes were absent and bilateral lower extremity vibra-
tion sensation was also absent. On ophthalmologic
examination, she had diabetic microangiopathies and
growth arrest retinopathy. She demonstrated peripheral
and autonomic neuropathy and had evidence of diabetic
nephropathy of the third stage, i.e., overt proteinuria had
been diagnosed, and her estimated glomerular filtration
rate was 139.7 mL/min/1.73m2. She had no evidence of
chronic thyroiditis (anti-thyroglobulin antibodies 11 IU/mL
and anti-thyroid peroxidase antibodies 7 IU/mL; normal
range: ≤ 28 IU/mL and ≤ 16 IU/mL, respectively).
Due to financial difficulties, she was only able to afford
outpatient visits once every 2 months. Her HbA1c at this
time remained at 13 %. In April 2009, she was repeatedly
hospitalized with dehydration and diabetic ketoacidosis
(DKA) due to the interruption of insulin injections
because of frequent vomiting that had appeared in
response to stressful events. At that time, vomiting epi-
sodes occurred more than 30 times a day, and hematem-
esis was also observed. Nausea and increased salivation
always persisted. Episodes were so severe that the patient
was often found lying on the floor unresponsive and
nearly unconscious. In addition, both fever and elevation
of blood pressure were observed. For antiemetic therapy,
intravenous administration of both diazepam and meto-
clopramide were ineffective, but intravenous administra-
tion of haloperidol was slightly effective. From around
the 4th or 5th day after admission, vomiting gradually im-
proved. During the period of vomiting, excessive secre-
tion of both ACTH and ADH were observed, but they
promptly improved during remission (Table 1). As a
result of psychological intervention (behavioral therapy
to include a combination of counseling and autogenic
training, etc.) by a clinical psychologist, glycemic control
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showed temporary improvement (Fig. 2a). However, in
December of the same year, we began CSII treatment
during the vomiting phase because self-injection of insu-
lin was interrupted and glycemic control had become
more difficult with her HbA1c showing another upward
trend (Fig. 2a). As a result, she no longer developed
DKA during the periods of vomiting and was capable of
maintaining her activities of daily living, while repeated
cycles of vomiting remitted and glycemic control also
showed a trend toward improvement (Fig. 2a, b).
Subsequently, around March 2011, the patient’s vomit-
ing episodes worsened and were more prolonged. She
had a prolonged period of hospitalization, and her daily
life again became difficult. Although her nutrition was
managed by nasogastric tube feedings and central ven-
ous nutrition, her body weight decreased significantly to
38.0 kg with a body mass index (BMI) of 15.2 kg/m2.
In February 2012, we started hypnotherapy. The
treatment was limited by poor language comprehen-
sion (Wechsler Adult Intelligence Scale-Third Edition
[WEIS-III] score was 60 points), and a developmental
disorder was inferred. Even so, the patient was able to
be discharged because vomiting frequency was reduced
by a combination of hypnotherapy and sandplay ther-
apy (Fig. 2b). Today, her episodes of vomiting have not
completely remitted, but it was possible to shift her to
outpatient management, and her HbA1c has also been
maintained at 7 %.
Discussion
In our case, violent vomiting began more than 30 times
a day without warning, and both nausea and vomiting
disappeared within a week. Furthermore, there were
more than 3 intermittent vomiting episodes per year,
and there was a period of remission of nausea and
vomiting between each episode. Migraine history was
observed in the patient’s mother. From the above, she
was considered to have met all of the diagnostic criteria.
However, we also believed it was necessary to exclude
celiac disease from the differential diagnosis, although
the frequency is very low in Japan.
In this case, vomiting attacks triggered by stress ap-
peared to evolve into a ketotic state with the observation
of abnormally high levels of ACTH and ADH, which im-
proved rapidly, along with recovery of vomiting (Table 1).
Moreover, the elevation of leukocytes (predominantly neu-
trophils), hypertension and elevation of body temperature
were observed during the vomiting period. We speculated
that the increased neutrophil predominance of leuko-
cytes without an increase in C-reactive protein (CRP)
and the significant elevation of both blood pressure and
fever reflected hypercortisolemia and the enhancement
of catecholamine release as well as PGE2 production
(catecholamines and PGE2 were not measured), re-
spectively. Sato et al. reported the case of an 8-year-old
girl with periodic attacks of vomiting. At the initiation
of the attack, ACTH and ADH levels were prominently
increased (610 pg/mL and about 82 pg/mL, respect-
ively), followed by hypercortisolemia (51-80 μg/dL)
[12]. Nakazato et al. described a 48-year-old woman
with several attacks of vomiting. Her abnormal labora-
tory results included leukocytes (12,500/μL), CRP
(0.54 mg/dL) and increased ACTH (196 pg/mL) [26].
Data from the cases shown in these reports were simi-
lar to those in our case (Table 1). In association with
hormonal variation, vomiting attacks have often been
found to overlap with menstruation. Shin et al. re-
ported a case of cyclic vomiting syndrome in an adult
patient characterized by stereotypical vomiting attacks
occurring during every menstrual period [27]. There-
fore, we considered it likely that this patient possessed
elements of menstrual-related CVS.
A satisfactory therapeutic method for the treatment of
ACVS has not yet been reported. So far, relaxation for
Table 1 Laboratory data for the vomiting attack period and after improvement (April 2009)
Vomiting period (Day 1) Remission period (Day 6) (Reference value)
ACTH (pg/mL) 229 ↑ ≤2.0↓ (7.2-63.3)
Cortisol (μg/mL) 55.0 ↑ 3.8 ↓ (4.0-18.3)
ADH (pg/mL) 102 ↑ 1.9 (0.3-3.5)
Serum osmolarity (mOsm/kg•H2O) 296 ↑ 282 (276-292)
Acetoacetic acid (μmol/L) 806 ↑ 10 (≤55)
3-hydroxybutyric acid (μmol/L) 2380 ↑ 54 (≤85)
Total ketone bodies (μmol/L) 3,186 ↑ 64 (≤130)
WBC (/μL) 14550a ↑ 7800 (3500-9000)
Neutrophil (%) 86.2a ↑ 55.3 (42.0-74.0)
CRP (mg/dL) 0.66a ↑ <0.06 (<0.06)
aindicates the value on Day 3 of vomiting period
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stress prevention and medications such as tricyclic anti-
depressants with CRF inhibitory action, benzodiazepines
with an anti-anxiety effect, 5-HT3 receptor antagonists
with an antiemetic effect, antihistamines, D2 receptor
antagonists and anti-migraine drugs (5-HT10 agonists)
have been tried. However, many of them were ineffective
in this case. In addition, very little antiemetic effect was
observed with the administration of diazepam, metoclo-
pramide and domperidone. Only haloperidol administra-
tion was relatively effective, but the mechanism was
unknown. On the other hand, appropriate methods of
coping with stress were considered to be important in
the prevention of the onset of vomiting. Although we
worked in conjunction with a clinical psychologist to im-
prove the patient’s coping skills after remission of a
vomiting attack, it was not possible to reduce the
frequency of vomiting episodes. This is in contrast to
the reported efficacy of hypnotherapy in the suppression
of nausea and vomiting during cancer chemotherapy
[28] as well as its remarkable antiemetic effect on hyper-
emesis gravidarum [29].
Kihlstrom et al. declared that hypnosis is a social inter-
action in which the subject (patient) responds to sugges-
tions offered by the hypnotist (healer) for imaginative
experiences involving alterations in conscious perception
and memory and the voluntary control of action [30].
The healing principle has not been clarified yet; however,
it is believed the hypnotic phenomenon engages the
patient’s own problem-solving skills and develops the
patient’s absolute trust in his or her proactive problem-
solving ability. The understanding and use of the hyp-



















Fig. 2 Transition of HbA1c (a) and vomiting episode frequency (b). a: Line graph linked by open circles shows the change in HbA1c; black
rectangle shows the duration of continuous subcutaneous insulin infusion therapy. b: Histogram showing the episodes of vomiting attacks; white
rectangle shows the duration of counseling, relaxation, cognitive behavioral therapy and psychological education by a clinical psychologist; gray
rectangle shows the duration of hypnotherapy; and arrows indicate miniature garden therapy. During a total of 40 hospitalizations, nurses and
doctors were committed to not only treating the patient medically but also providing emotional and social support
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between the patient and healer. From this standpoint,
hypnotherapy can be expressed as non-verbal empower-
ment. It is believed that it is important to be sympathetic
to the patients’ individual characteristic responses. In
our patient, catalepsy, lacrimation, fear, an increase in
body temperature and hypnotic responses indicating
specific difficulties, such as colorless visions and feelings
of floating than heaviness, were present. We presumed
the relationship between CVS and harsh life events
(traumatic experience, experience of loss, etc.) took
place at a crucial time in this patient’s psychological de-
velopment based on her developmental disorder and
background of complex type 1 diabetes. At the same
time, it was revealed that the origin of the illness could
be related to underlying economic problems, lack of affec-
tion, etc. (Fig. 3), while the developmental disorder inferred
by her WEIS-III score became a barrier to communication.
However, when she was given suggestions under hypnotic
induction and trance, it was possible for her to imagine a
visual stimulus in a unique way to understand the various
events. This was reinforced by sandplay therapy. With these
interventions, there is a strong possibility that the effect of
hypnotherapy raised her capacity for self-control of bodily
sensations and emotions. As a result, the patient’s own
emotional expression and self-insight were promoted with
counseling and psychological education. Building a relation-
ship with the patient and clarifying the roles of doctors and
nurses continued, and those relationships appeared to func-
tion more effectively.
Conclusions
We have reported a case of a patient with type 1 dia-
betes with ACVS. When the characteristic vomiting epi-
sodes are seen in patients with type 1 diabetes, it is
necessary to take into account the possible overlay of
ACVS. A combination of CSII, comprehensive psycho-
therapy including hypnotherapy and sandplay therapy
and a commitment to the patient as a team, including a
clinical psychologist, should be considered useful in
attaining glycemic control and vomiting control for such
patients.
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